StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Eli Lilly & Co. (LLY) Reports RNAi Licensing & Research Collaboration with Dicerna Pharmaceuticals (DRNA)
October 29, 2018 6:13 AM
Eli Lilly and Company (NYSE: LLY) and Dicerna Pharmaceuticals (NASDAQ: DRNA) today announced a global licensing and research collaboration focused ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Management Comments
Next Articles
Lilly and Dicerna Announce RNAi Licensing and Research Collaboration
October 29, 2018 6:00 AM